These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 6126268)

  • 1. Calcitonin, somatostatin and ACTH immunoreactive cells in a case of familial bilateral thyroid medullary carcinoma.
    Charpin C; Andrac L; Monier-Faugere MC; Hassoun J; Cannoni M; Vagneur JP; Toga M
    Cancer; 1982 Nov; 50(9):1806-14. PubMed ID: 6126268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunohistochemical detection of calcitonin, ACTH, beta-MSH, beta-endorphin and somatostatin in medullary carcinoma of the thyroid. Immunoperoxidase study (PAP, ABC) of 10 cases].
    Charpin C; Argemi B; Cannoni M; Oliver C; Gillioz P; Vagneur JP; Toga M
    Ann Pathol; 1984; 4(1):27-35. PubMed ID: 6142718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occurrence of calcitonin, somatostatin-like immunoreactivity, and carcinoembryonic antigen in two sisters suffering from familial thyroid medullary carcinoma.
    Bethge N; Ahuja S; Diel F
    Exp Clin Endocrinol; 1986 Dec; 88(3):365-72. PubMed ID: 2881797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple endocrine cell types in thyroid medullary carcinoma. Evidence for calcitonin, somatostatin, ACTH, 5HT and small granule cells.
    Capella C; Bordi C; Monga G; Buffa R; Fontana P; Bonfanti S; Bussolati G; Solcia E
    Virchows Arch A Pathol Anat Histol; 1978 Feb; 377(2):111-28. PubMed ID: 205037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatostatin-immunoreactive cells in medullary carcinoma of the thyroid.
    Sundler F; Alumets J; Håkanson R; Björklund L; Ljungberg O
    Am J Pathol; 1977 Aug; 88(2):381-6. PubMed ID: 195473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medullary thyroid carcinoma and calcitonin.
    Emmertsen K
    Dan Med Bull; 1985 Mar; 32(1):1-28. PubMed ID: 2859145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medullary differentiation of anaplastic thyroid carcinoma.
    Nieuwenhuijzen Kruseman AC; Bosman FT; van Bergen Henegouw JC; Cramer-Knijnenburg G; Brutel de la Riviere G
    Am J Clin Pathol; 1982 May; 77(5):541-7. PubMed ID: 6177234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A compound follicular-parafollicular cell carcinoma of the thyroid: a new tumor entity?
    Ljungberg O; Ericsson UB; Bondeson L; Thorell J
    Cancer; 1983 Sep; 52(6):1053-61. PubMed ID: 6136320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistological studies of medullary thyroid carcinoma and C cell hyperplasia.
    Deftos LJ; Bone HG; Parthemore JG
    J Clin Endocrinol Metab; 1980 Oct; 51(4):857-62. PubMed ID: 6106648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An efficient method to detect calcitonin mRNA in normal and neoplastic rat C-cells (medullary thyroid carcinoma) by in situ hybridization using a digoxigenin-labeled synthetic oligodeoxyribonucleotide probe.
    Le Guellec P; Dumas S; Volle GE; Pidoux E; Moukhtar MS; Treilhou-Lahille F
    J Histochem Cytochem; 1993 Mar; 41(3):389-95. PubMed ID: 8429201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatostatin inhibits the pentagastrin-induced release of serum calcitonin in medullary carcinoma of the thyroid.
    Gordin A; Lamberg BA; Pelkonen R; Almqvist S
    Clin Endocrinol (Oxf); 1978 Apr; 8(4):289-93. PubMed ID: 647984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of gastrin releasing peptide by medullary carcinoma of the thyroid. An immunohistochemical study.
    Kameya T; Bessho T; Tsumuraya M; Yamaguchi K; Abe K; Shimosato Y; Yanaihara N
    Virchows Arch A Pathol Anat Histopathol; 1983; 401(1):99-107. PubMed ID: 6412451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medullary carcinoma of the thyroid. An immunocytochemical and histochemical study of 25 cases using eight separate markers.
    Sikri KL; Varndell IM; Hamid QA; Wilson BS; Kameya T; Ponder BA; Lloyd RV; Bloom SR; Polak JM
    Cancer; 1985 Nov; 56(10):2481-91. PubMed ID: 2412687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ACTH and calcitonin secreting medullary carcinoma of the thyroid.
    Croughs RJ; Eastham WN; Hackeng WH; Schopman W; Feltkamp-Vroom TM; Dolman A; Hennemann G
    Clin Endocrinol (Oxf); 1972 Apr; 1(2):157-71. PubMed ID: 4352168
    [No Abstract]   [Full Text] [Related]  

  • 15. Occult medullary carcinoma of thyroid: an unusual clinical and pathologic presentation.
    White IL; Vimadalal SD; Catz B; Van de Velde R; LaGanga T
    Cancer; 1981 Mar; 47(6):1364-8. PubMed ID: 7226060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Normal preoperative calcitonin levels do not always exclude medullary thyroid carcinoma in patients with large palpable thyroid masses.
    Redding AH; Levine SN; Fowler MR
    Thyroid; 2000 Oct; 10(10):919-22. PubMed ID: 11081258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial and sporadic medullary thyroid carcinoma: clinical and immunohistological findings.
    Ekblom M; Välimäki M; Pelkonen R; Jansson R; Sivula A; Franssila K
    Q J Med; 1987 Nov; 65(247):899-910. PubMed ID: 2901773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medullary carcinoma of the thyroid as a cause of Cushing's syndrome: a case with ectopic adrenocorticotropin secretion characterized by double enzyme immunostaining.
    Hijazi YM; Nieman LK; Medeiros LJ
    Hum Pathol; 1992 May; 23(5):592-6. PubMed ID: 1568756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrastructural study of thyroid medullary carcinoma.
    Kakudo K; Miyauchi A; Katayama S
    Acta Pathol Jpn; 1977 Sep; 27(5):605-22. PubMed ID: 201148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medullary carcinoma of the thyroid.
    Hollenberg CH
    Arch Otolaryngol; 1983 Feb; 109(2):103-5. PubMed ID: 6849663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.